{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:33:57Z","timestamp":1792240437304,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013871","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000}}],"reference-count":128,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013871.pub2","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T20:15:51Z","timestamp":1682367351000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Fecal microbiota transplantation for the treatment of recurrent\n                    <i>Clostridioides difficile<\/i>\n                    (\n                    <i>Clostridium difficile<\/i>\n                    )"],"prefix":"10.1002","volume":"2023","author":[{"given":"Nathan Zev","family":"Minkoff","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Hepatology and Nutrition; Valley Children's Hospital; Madera California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scheherzade","family":"Aslam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; University of Nebraska Medical Center; Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Medina","sequence":"additional","affiliation":[{"name":"Department of Public Health and Preventative Medicine; SUNY Upstate Medical University; Syracuse, New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E","family":"Tanner-Smith","sequence":"additional","affiliation":[{"name":"Counseling Psychology and Human Services; University of Oregon; Eugene Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P","family":"Zackular","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; University of Pennsylvania and Children\u2019s Hospital of Philadelphia; Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Acra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth R","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Imdad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; SUNY Upstate Medical University; Syracuse New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD013871.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD013871.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/cid\/ciw731","article-title":"Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial","volume":"64","author":"Hota","year":"2017","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD013871.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection","volume":"156","author":"Hvas","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013871.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection \u2013 a randomized trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e01965","DOI":"10.1128\/mBio.01965-16","article-title":"Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation","volume":"7","author":"Staley","year":"2016","journal-title":"mBio"},{"issue":"9","key":"10.1002\/14651858.CD013871.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/apt.16309","article-title":"Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections","volume":"53","author":"Rode","year":"2021","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD013871.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"Nood","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"S540","DOI":"10.1016\/S0016-5085(16)31855-8","article-title":"Fecal microbiota transplantation delivered via oral capsules achieves microbial engraftment similar to traditional delivery modalities: safety, efficacy and engraftment results from a multi-center cluster randomized dose-finding study","volume":"150","author":"Allegretti","year":"2016","journal-title":"American Gastroenterological Association Abstracts"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0009|cit9","first-page":"S540","article-title":"Fecal microbiota transplantation delivered via oral capsules achieves microbial engraftment similar to traditional delivery modalities: safety, efficacy and engraftment results from a multi-center cluster randomized dose-finding study","volume":"1","author":"Allegretti","year":"2016","journal-title":"Digestive Disease Week"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s10620-018-5396-6","article-title":"Fecal microbiota transplantation capsules with targeted colonic versus gastric delivery in recurrent Clostridium difficile infection: a comparative cohort analysis of high and lose dose","volume":"64","author":"Allegretti","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1590-8658(17)30354-7","article-title":"Fecal microbiota transplantation via enema for recurrent Clostridium difficile infection modulates the inflammatory host response and restores intestinal dysbiosis","volume":"49","author":"Cicerone","year":"2017","journal-title":"Digestive and Liver Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013871.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"S381","DOI":"10.1093\/ofid\/ofx163.943","article-title":"Lyophilized fecal microbiota transplantation capsules for recurrent Clostridium difficile infection","volume":"4","author":"Dupont","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/2050640615616068","article-title":"A multi-center, cluster randomized dose-finding study of fecal microbiota transplantation capsules for recurrent Clostridium difficile infection","volume":"3","author":"Fischer","year":"2015","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10620-017-4833-2","article-title":"Fecal transplantation for treatment of Clostridium difficile infection in elderly and debilitated patients","volume":"63","author":"Friedman-Korn","year":"2018","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"4549298","DOI":"10.1155\/2019\/4549298","article-title":"Intestinal microbiome changes in fecal microbiota transplant (FMT) vs. FMT enriched with Lactobacillus in the treatment of recurrent Clostridioides difficile infection","volume":"2019","author":"Garza-Gonzalez","year":"2019","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/apt.14816","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection \u2013 single versus multiple infusions","volume":"48","author":"Ianiro","year":"2018","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD013871.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S1590-8658(18)30265-2","article-title":"Randomized clinical trial: single-infusion FMT versus multiple-infusion FMT for the treatment of severe C. difficile infection","volume":"50","author":"Ianiro","year":"2018","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/apt.13969","article-title":"Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridium difficile infection \u2013 fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy","volume":"45","author":"Jiang","year":"2017","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"e0205064","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLOS One"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S892","DOI":"10.1016\/S0016-5085(18)33011-7","article-title":"The effect of type of inoculum and administration route of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection","volume":"154","author":"Jiang","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0021|cit21","unstructured":"Fecal microbiota transplantation for Clostridium difficile infection trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000016900"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0022|cit22","unstructured":"Fecal microbiota transplantation for refractory Clostridium difficile infection trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000019181"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0023|cit23","unstructured":"Fecal microbiota transplantation for Clostridium difficile infection trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000020766"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S553","DOI":"10.14309\/00000434-201510001-01258","article-title":"A dual center, randomized trial comparing colonoscopy and oral capsule delivered fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection: preliminary results","volume":"110","author":"Kao","year":"2015","journal-title":"American Journal of Gastroenterology"},{"issue":"20","key":"10.1002\/14651858.CD013871.pub2-BIB0025|cit25","first-page":"71","article-title":"A prospective, dual center, randomized trial comparing colonoscopy versus capsule delivered fecal microbiota transplantation in the management of recurrent Clostridium difficile infection","volume":"318","author":"Kao","year":"2016","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD013871.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.conctc.2020.100576","article-title":"Fecal microbiota transplantation for patients on antibiotic treatment with C. difficile infection history (GRAFT): study protocol for a phase II, randomized, double-blind, placebo-controlled trial to prevent recurrent C. difficile infections","volume":"18","author":"Kates","year":"2020","journal-title":"Contemporary Clinical Trials Communications"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0028|cit28","unstructured":"The GRAFT study: gut recolonization by fecal transplantation (GRAFT) clinicaltrials.gov\/ct2\/show\/NCT03621657"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10096-019-03602-2","article-title":"Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure","volume":"38","author":"Lee","year":"2019","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"11-2","key":"10.1002\/14651858.CD013871.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/23744235.2018.1500709","article-title":"Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection","volume":"50","author":"Martinez","year":"2018","journal-title":"Infectious Diseases"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0032|cit32","unstructured":"Multi-centre trial of fresh vs. frozen-and-thawed FMT for recurrent CDI clinicaltrials.gov\/ct2\/show\/NCT01398969"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0033|cit33","unstructured":"Fecal microbiota transplant (FMT) for relapsing C. difficile infection in adults and children using a frozen inoculum clinicaltrials.gov\/ct2\/show\/NCT01704937"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0034|cit34","unstructured":"FMT delivered by capsule versus colonoscopy for recurrent C. diff clinicaltrials.gov\/ct2\/show\/NCT02254811"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0035|cit35","unstructured":"Fresh, frozen or lyophilized fecal microbiota transplantation for multiple recurrent C. difficile associated diarrhea clinicaltrials.gov\/ct2\/show\/NCT02318992"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0036|cit36","unstructured":"Dose ranging study of the safety and efficacy of orally administered lyophilized fecal microbiota product (PRIM-DJ2727) for the treatment of recurrent Clostridium difficile infection (Cdi) clinicaltrials.gov\/ct2\/show\/NCT03298048"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0037|cit37","unstructured":"Fecal microbiota transplantation for severe Clostridium difficile infection clinicaltrials.gov\/ct2\/show\/NCT03427229"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0038|cit38","unstructured":"Fecal microbiota transplant by oral capsules enriched with Lactobacilli for recurrent Clostridium difficile infection clinicaltrials.gov\/ct2\/show\/NCT03804736"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/apt.13009","article-title":"Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection \u2013 an observational cohort study","volume":"41","author":"Satokari","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013871.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/ofid\/ofw172.1044","article-title":"Efficacy and safety of RBX2660 for the prevention of recurrent Clostridium difficile infection: results of the PUNCH CD 2 trial","volume":"3","author":"Dubberke","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD013871.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/cid\/ciy259","article-title":"Results from a randomized, placebo-controlled clinical trial of a RBX2660 \u2013 a microbiota-based drug for the prevention of recurrent Clostridium difficile infection","volume":"67","author":"Dubberke","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD013871.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"S951","DOI":"10.1016\/S0016-5085(17)33238-9","article-title":"Lack of association with patient demographics and outcomes in PUNCH CD2, a randomized controlled trial of RBX2660, a microbiota-based drug for recurrent Clostridium difficile infection","volume":"152","author":"Hecht","year":"2017","journal-title":"American Gastroenterological Association Abstracts"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0044|cit44","unstructured":"Microbiota restoration therapy for recurrent Clostridium difficile infection (Punchcd2) clinicaltrials.gov\/ct2\/show\/NCT02299570"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.14309\/00000434-201610001-00194","article-title":"Durable prevention of recurrent C. difficile infection with RBX2660: results of the PUNCH CD 2 trial","volume":"111","author":"Ramesh","year":"2016","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0046|cit46","first-page":"S","article-title":"Effect of lyophilized sterile fecal filtrate vs lyophilized donor stool on recurrent Clostridoides difficile infection: preliminary results from a randomized, double-blind pilot study","volume":"156","author":"Kao","year":"2019","journal-title":"American Gastroenterological Association Abstracts"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0047|cit47","unstructured":"Lyophilized fecal transplant vs lyophilized fecal filtrate in recurrent C diff infection clinicaltrials.gov\/ct2\/show\/NCT03353506"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0048|cit48","unstructured":"Safety and efficacy of FMT in individuals with one or more recurrences of Clostridium difficile associated disease (CDAD) clinicaltrials.gov\/ct2\/show\/NCT03548051"},{"issue":"5","key":"10.1002\/14651858.CD013871.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/17407745211021198","article-title":"Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: a clinical trial with novel home-based enrollment","volume":"18","author":"Drekonja","year":"2021","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0050|cit50","unstructured":"Rectal bacteriotherapy, faecal microbiota transplantation or oral vancomycin for the treatment of recurrent Clostridium difficile infection: a randomised controlled trial clinicaltrialsregister.eu\/ctr-search\/trial\/2015-003062-82\/DK"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0051|cit51","unstructured":"FMT versus antimicrobials for initial treatment of recurrent CDI clinicaltrials.gov\/ct2\/show\/NCT02255305"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0052|cit52","unstructured":"Rectal bacteriotherapy, fecal microbiota transplantation or oral vancomycin treatment of recurrent Clostridium difficile infections clinicaltrials.gov\/ct2\/show\/NCT02774382"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0053|cit53","unstructured":"Microbiota or placebo after antimicrobial therapy for recurrent C. difficile at home (MATCH) clinicaltrials.gov\/ct2\/show\/NCT03005379"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0054|cit54","unstructured":"A novel faecal microbiota transplantation system for treatment of primary and recurrent Clostridium difficile infection (FMTREAT) clinicaltrials.gov\/ct2\/show\/NCT03053505"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0055|cit55","unstructured":"Multicentre blinded comparison of lyophilized sterile fecal filtrate to lyophilized fecal microbiota transplant in recurrent Clostridioides difficile infection clinicaltrials.gov\/ct2\/show\/NCT03806803"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0056|cit56","unstructured":"PMT for severe-CDI clinicaltrials.gov\/ct2\/show\/NCT03970200"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0057|cit57","unstructured":"Fecal microbiota transplantation for early Clostridioides difficile infection (EarlyFMT) clinicaltrials.gov\/ct2\/show\/NCT04885946"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0058|cit58","unstructured":"Fecal filtrate as a treatment option of multiple recurrent Clostridioides difficile infection (FILTRATE) clinicaltrials.gov\/ct2\/show\/NCT04960306"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0059|cit59","unstructured":"Bezlotoxumab versus FMT for multiple recurrent CDI (BSTEP) clinicaltrials.gov\/ct2\/show\/NCT05077085"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0060|cit60","unstructured":"Recurrent Clostridioides difficile infection treatment with capsules of lyophilised faecal microbiota vs fidaxomicin clinicaltrials.gov\/ct2\/show\/NCT05201079"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0061|cit61","unstructured":"Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first recurrence (FENDER) clinicaltrials.gov\/ct2\/show\/NCT05266807"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-019-0677-6","article-title":"Clinical review on the utility of fecal microbiota transplantation in immunocompromised patients","volume":"21","author":"Abu-Sbeih","year":"2019","journal-title":"Current Gastroenterology Reports"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0064|cit64","first-page":"e2778","article-title":"Fidaxomicin vs vancomycin for the treatment of a first episode of Clostridium difficile infection: a meta-analysis and systematic review","volume":"10","author":"Al Momani","year":"2018","journal-title":"Cureus Journal of Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"ofv004","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD013871.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"010407","DOI":"10.7189\/jogh.09.010407","article-title":"Global burden of Clostridium difficile infections: a systematic review and meta-analysis","volume":"9","author":"Balsells","year":"2019","journal-title":"Journal of Global Health"},{"issue":"29-30","key":"10.1002\/14651858.CD013871.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"100642","DOI":"10.1016\/j.eclinm.2020.100642","article-title":"Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis","volume":"23","author":"Baunwall","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0070|cit70","unstructured":"US Department of Health and Human Services Antibiotic resistance threats in the United States, 2019 cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"issue":"3","key":"10.1002\/14651858.CD013871.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/525047","article-title":"Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea","volume":"197","author":"Chang","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0072|cit72","unstructured":"Covidence Veritas Health Innovation"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"e00021","DOI":"10.1128\/CMR.00021-17","article-title":"Understanding Clostridium difficile colonization","volume":"31","author":"Crobach","year":"2018","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0000000000002205","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection and other conditions in children: a joint position paper from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition","volume":"68","author":"Davidovics","year":"2019","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40121-020-00356-9","article-title":"Fecal microbiota transplantation may be the best option in treating multiple Clostridioides difficile infection: a network meta-analysis","volume":"10","author":"Dembrovszky","year":"2020","journal-title":"Infectious Diseases & Therapy"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"PLOS Biology"},{"issue":"9","key":"10.1002\/14651858.CD013871.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M14-2693","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: a systematic review","volume":"162","author":"Drekonja","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"7547","key":"10.1002\/14651858.CD013871.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bmj.332.7547.969","article-title":"Reporting attrition in randomised controlled trials","volume":"332","author":"Dumville","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0079|cit79","unstructured":"US Department of Health and Human Services Food and Drug Administration: Center for Biologics Evaluation and Research Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies fda.gov\/media\/86440\/download"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0080|cit80","unstructured":"Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0081|cit81","unstructured":"Fecal microbiota for transplantation: safety alert \u2013 risk of serious adverse events likely due to transmission of pathogenic organisms fda.gov\/safety\/medical-product-safety-information\/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0082|cit82","unstructured":"Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19 fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/safety-alert-regarding-use-fecal-microbiota-transplantation-and-additional-safety-protections"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.1993.03500010081036","article-title":"Diagnosis and treatment of Clostridium difficile colitis","volume":"269","author":"Fekety","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD013871.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","article-title":"Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial","volume":"24","author":"Fekety","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013871.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspectives in Clinical Research"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"e0210016","DOI":"10.1371\/journal.pone.0210016","article-title":"Fecal microbiota transplantation for treatment of recurrent C. difficile infection: an updated randomized controlled trial meta-analysis","volume":"14","author":"Hui","year":"2019","journal-title":"PLOS One"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/apt.14816","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection \u2013 single versus multiple infusions","volume":"48","author":"Ianiro","year":"2018","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012774.pub2","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","author":"Imdad","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"e0205064","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD013871.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/tgh.2019.05.10","article-title":"Fecal microbiota transplantation: great potential with many challenges","volume":"4","author":"Kellermayer","year":"2019","journal-title":"Translational Gastroenterology and Hepatology"},{"issue":"18","key":"10.1002\/14651858.CD013871.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile \u2013 more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013871.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"Kelly","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook","volume":"129","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2020.09.038","article-title":"Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry","volume":"160","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/MEG.0000000000001243","article-title":"Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"30","author":"Khan","year":"2018","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-017-0269-3","article-title":"Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease","volume":"5","author":"Khanna","year":"2017","journal-title":"Microbiome"},{"issue":"3","key":"10.1002\/14651858.CD013871.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrgastro.2015.220","article-title":"Breakthroughs in the treatment and prevention of Clostridium difficile infection","volume":"13","author":"Kociolek","year":"2016","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.anaerobe.2016.06.008","article-title":"Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Pr\u00e9vot 1938","volume":"40","author":"Lawson","year":"2016","journal-title":"Anaerobe"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0105|cit105","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"16","key":"10.1002\/14651858.CD013871.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013871.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.dld.2016.08.110","article-title":"Endoscopic peroral jejunal fecal microbiota transplantation","volume":"48","author":"Link","year":"2016","journal-title":"Digestive & Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/511798","article-title":"Recommendations for surveillance of Clostridium difficile-associated disease","volume":"28","author":"McDonald","year":"2007","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD013871.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0111|cit111","unstructured":"Microsoft Excel Microsoft Corporation 2018"},{"issue":"11","key":"10.1002\/14651858.CD013871.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD013871.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cellular Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/lam.13486","article-title":"Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis","volume":"73","author":"Veses","year":"2021","journal-title":"Letters in Applied Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD013871.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10620-020-06185-7","article-title":"Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent Clostridioides difficile infection: a systematic review and meta-analysis","volume":"66","author":"Ramai","year":"2021","journal-title":"Digestive Diseases and Sciences"},{"issue":"8","key":"10.1002\/14651858.CD013871.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ajg.2016.187","article-title":"Recurrence of Clostridium difficile infection in patients with inflammatory bowel disease: the RECIDIVISM study","volume":"111","author":"Razik","year":"2016","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0118|cit118","first-page":"288","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","year":"2018"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0119|cit119","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0120|cit120","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2020"},{"issue":"8","key":"10.1002\/14651858.CD013871.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/2050640619854587","article-title":"A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection","volume":"7","author":"Rokkas","year":"2019","journal-title":"United European Gastroenterology Journal"},{"issue":"6","key":"10.1002\/14651858.CD013871.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2021.01.010","article-title":"Long-term safety of fecal microbiota transplantation for recurrent Clostridioides difficile infection","volume":"160","author":"Saha","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013871.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"c1296","DOI":"10.1136\/bmj.c1296","article-title":"Prevention and medical management of Clostridium difficile infection","volume":"340","author":"Shannon-Lowe","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/ciu278","article-title":"Tempered enthusiasm for fecal transplant","volume":"59","author":"Solari","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"366","key":"10.1002\/14651858.CD013871.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013871.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2012.01.004","article-title":"Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence","volume":"40","author":"Vardakas","year":"2012","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"4","key":"10.1002\/14651858.CD013871.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/JCM.02327-16","article-title":"Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"55","author":"Woodworth","year":"2017","journal-title":"Journal of Clinical Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD013871.pub2-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013871","article-title":"Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile ( Clostridium difficile)","author":"Imdad","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T01:23:16Z","timestamp":1713835396000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013871.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":128,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013871.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}